Belvedere Trading’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,701	Closed	-$6.33K	–	738
2022 Q4	$6.33K	Buy	+5,701	New	+$6.33K	﹤0.01%	300